TIZANIDINE

TIZANIDINE was reported 24114 times

TIZANIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAILURE TO SUSPEND MEDICATION 19 0.0918
1 STIFF PERSON SYNDROME 19 0.0548
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 49 0.0461
3 HYPERPARATHYROIDISM SECONDARY 106 0.0423
4 INFECTED DERMAL CYST 15 0.0416
5 REBOUND ACID HYPERSECRETION 120 0.0396
6 NEPHROGENIC ANAEMIA 183 0.0395
7 SUSPECTED SUICIDE 139 0.0296
8 ARTERIOVENOUS FISTULA 14 0.0285
9 BONE DEMINERALISATION 18 0.0170
10 END STAGE RENAL DISEASE 279 0.0153
11 CHRONIC KIDNEY DISEASE 1116 0.0147
12 DRY AGE-RELATED MACULAR DEGENERATION 16 0.0144
13 MUSCLE SPASTICITY 172 0.0140
14 ENCEPHALOPATHY 341 0.0139
15 GASTROINTESTINAL HYPOMOTILITY 31 0.0137
16 ACCIDENTAL DEATH 25 0.0134
17 B-LYMPHOCYTE COUNT DECREASED 18 0.0132
18 PROGRESSIVE MULTIPLE SCLEROSIS 15 0.0130
19 LUMBAR RADICULOPATHY 15 0.0129
20 JC POLYOMAVIRUS TEST POSITIVE 14 0.0120
21 IMPAIRED GASTRIC EMPTYING 163 0.0119
22 PERONEAL NERVE PALSY 63 0.0111
23 ESSENTIAL HYPERTENSION 19 0.0104
24 LUMBAR SPINAL STENOSIS 29 0.0099
25 CERVICAL SPINAL STENOSIS 17 0.0099
26 DRUG SCREEN NEGATIVE 17 0.0097
27 PARAPARESIS 17 0.0095
28 INTERVERTEBRAL DISC DEGENERATION 80 0.0086
29 BLADDER DISORDER 85 0.0086
30 NEUROGENIC BLADDER 18 0.0085
31 NECK SURGERY 19 0.0082
32 DERMAL CYST 20 0.0081
33 WHEELCHAIR USER 36 0.0081
34 MULTIPLE SCLEROSIS RELAPSE 550 0.0080
35 NERVE COMPRESSION 74 0.0080
36 SPINAL STENOSIS 33 0.0080
37 FIBULA FRACTURE 23 0.0080
38 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 15 0.0080
39 INFUSION SITE BRUISING 17 0.0079
40 RENAL INJURY 233 0.0078
41 PNEUMONIA ASPIRATION 194 0.0078
42 VITAMIN D DEFICIENCY 74 0.0076
43 TOXIC ENCEPHALOPATHY 38 0.0075
44 HYPOREFLEXIA 14 0.0073
45 SPINAL OSTEOARTHRITIS 64 0.0073
46 WALKING AID USER 47 0.0071
47 NEURALGIA 173 0.0071
48 INTERVERTEBRAL DISC PROTRUSION 155 0.0071
49 MACULOPATHY 25 0.0070
50 COMPLETED SUICIDE 580 0.0070
51 PERICARDIAL HAEMORRHAGE 15 0.0069
52 INTERVERTEBRAL DISC DISORDER 29 0.0068
53 CERVICAL VERTEBRAL FRACTURE 23 0.0067
54 SPINAL FUSION SURGERY 27 0.0066
55 WRONG PATIENT RECEIVED PRODUCT 19 0.0065
56 MULTIPLE SCLEROSIS 310 0.0065
57 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 15 0.0064
58 SINUS PAIN 15 0.0064
59 SPINAL OPERATION 78 0.0063
60 URINARY HESITATION 15 0.0063
61 INTRACRANIAL ANEURYSM 25 0.0062
62 RENAL TUBULAR NECROSIS 61 0.0062
63 AUTONOMIC NERVOUS SYSTEM IMBALANCE 18 0.0062
64 ANKLE FRACTURE 95 0.0061
65 CONCUSSION 47 0.0061
66 BLOOD PRESSURE SYSTOLIC ABNORMAL 15 0.0061
67 BREAKTHROUGH PAIN 14 0.0060
68 SKIN ABRASION 28 0.0059
69 BLOOD PRESSURE DIASTOLIC ABNORMAL 15 0.0059
70 SEROTONIN SYNDROME 112 0.0058
71 SPINAL DISORDER 55 0.0058
72 UMBILICAL HERNIA 27 0.0058
73 TIBIA FRACTURE 27 0.0058
74 ANHEDONIA 151 0.0057
75 INFUSION SITE PRURITUS 18 0.0057
76 VITAMIN B12 DEFICIENCY 23 0.0057
77 CARTILAGE INJURY 14 0.0057
78 POST-TRAUMATIC STRESS DISORDER 38 0.0057
79 SCOLIOSIS 35 0.0056
80 MUSCLE TIGHTNESS 90 0.0056
81 FIBROMYALGIA 135 0.0055
82 SPONDYLITIS 20 0.0055
83 CLONUS 15 0.0055
84 OSTEOPENIA 83 0.0055
85 NECK INJURY 16 0.0054
86 DECREASED INTEREST 32 0.0054
87 ACUTE KIDNEY INJURY 825 0.0054
88 ANAL HAEMORRHAGE 15 0.0054
89 ANAL INCONTINENCE 48 0.0053
90 RENAL FAILURE 707 0.0053
91 TOOTH INJURY 23 0.0053
92 PRE-EXISTING CONDITION IMPROVED 33 0.0053
93 NERVE INJURY 58 0.0052
94 LYMPHOCYTE COUNT INCREASED 17 0.0052
95 HYPERTONIC BLADDER 15 0.0052
96 SLEEP APNOEA SYNDROME 99 0.0052
97 CENTRAL NERVOUS SYSTEM LESION 71 0.0052
98 SPINAL COLUMN STENOSIS 24 0.0051
99 HYPERTONIA 29 0.0051
100 GASTROOESOPHAGEAL REFLUX DISEASE 407 0.0051
101 FOOT OPERATION 25 0.0050
102 THERAPY CESSATION 256 0.0050
103 TRIGEMINAL NEURALGIA 20 0.0050
104 LIGAMENT SPRAIN 49 0.0050
105 TEMPERATURE INTOLERANCE 51 0.0049
106 HOMICIDAL IDEATION 20 0.0049
107 EXOSTOSIS 45 0.0049
108 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
109 TUBULOINTERSTITIAL NEPHRITIS 92 0.0049
110 SCIATICA 78 0.0049
111 BEDRIDDEN 64 0.0049
112 MIGRAINE 464 0.0049
113 BACK DISORDER 79 0.0049
114 SPINAL PAIN 56 0.0048
115 RESPIRATORY RATE DECREASED 15 0.0048
116 FUNGAL SKIN INFECTION 19 0.0047
117 BALANCE DISORDER 406 0.0047
118 SHOULDER OPERATION 20 0.0047
119 BODY HEIGHT DECREASED 49 0.0046
120 INCONTINENCE 48 0.0045
121 COMA 215 0.0045
122 FOOT FRACTURE 85 0.0045
123 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 215 0.0045
124 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
125 INFUSION SITE SWELLING 28 0.0044
126 URINARY TRACT INFECTION 759 0.0044
127 OSTEOARTHRITIS 188 0.0044
128 OPTIC NEURITIS 40 0.0044
129 MUSCLE STRAIN 38 0.0044
130 DYSSTASIA 127 0.0043
131 TROPONIN INCREASED 33 0.0043
132 SYNOVIAL CYST 20 0.0043
133 MUSCULOSKELETAL DISORDER 82 0.0043
134 CYSTITIS 137 0.0043
135 ECONOMIC PROBLEM 65 0.0043
136 MOBILITY DECREASED 305 0.0042
137 TONGUE DISCOMFORT 18 0.0042
138 MENISCUS INJURY 26 0.0042
139 PARANASAL SINUS DISCOMFORT 16 0.0042
140 TORSADE DE POINTES 33 0.0042
141 MICTURITION URGENCY 48 0.0042
142 CEREBRAL DISORDER 31 0.0042
143 FEELING DRUNK 31 0.0042
144 THYROID MASS 16 0.0042
145 OSTEOPOROSIS 170 0.0041
146 MONOCYTE COUNT INCREASED 15 0.0041
147 GAIT INABILITY 138 0.0041
148 RESTLESS LEGS SYNDROME 75 0.0041
149 MUSCULAR WEAKNESS 468 0.0041
150 SPINAL COMPRESSION FRACTURE 34 0.0041
151 MUSCLE RUPTURE 16 0.0041
152 SEASONAL ALLERGY 58 0.0041
153 HAND FRACTURE 29 0.0041
154 NECK PAIN 228 0.0041
155 FALL 1355 0.0041
156 CARPAL TUNNEL SYNDROME 57 0.0041
157 GAIT DISTURBANCE 777 0.0041
158 POST PROCEDURAL INFECTION 33 0.0041
159 BACK INJURY 44 0.0040
160 IMPAIRED QUALITY OF LIFE 58 0.0040
161 URINARY INCONTINENCE 119 0.0040
162 ESCHERICHIA URINARY TRACT INFECTION 17 0.0040
163 EAR PRURITUS 14 0.0040
164 HEAD INJURY 126 0.0040
165 MUSCLE SPASMS 730 0.0040
166 WITHDRAWAL SYNDROME 167 0.0040
167 GRIP STRENGTH DECREASED 35 0.0040
168 LOSS OF CONTROL OF LEGS 15 0.0040
169 PRODUCT ADMINISTRATION INTERRUPTED 31 0.0039
170 UROSEPSIS 36 0.0039
171 JOINT DISLOCATION 41 0.0039
172 VITAMIN D DECREASED 33 0.0039
173 SINUS DISORDER 76 0.0038
174 MEMORY IMPAIRMENT 527 0.0038
175 MOTOR DYSFUNCTION 39 0.0038
176 COVID-19 PNEUMONIA 45 0.0038
177 SOMNAMBULISM 25 0.0038
178 DYSGRAPHIA 25 0.0038
179 RIB FRACTURE 78 0.0038
180 STRESS CARDIOMYOPATHY 22 0.0038
181 IMPAIRED DRIVING ABILITY 43 0.0038
182 FEELING OF BODY TEMPERATURE CHANGE 22 0.0037
183 HIP SURGERY 20 0.0037
184 FACE INJURY 14 0.0037
185 MONOPLEGIA 16 0.0037
186 LYMPHOCYTE COUNT DECREASED 65 0.0037
187 WRIST FRACTURE 44 0.0037
188 HEMIPARESIS 62 0.0037
189 SELF-MEDICATION 15 0.0036
190 MELANOCYTIC NAEVUS 16 0.0036
191 NEPHROPATHY 34 0.0036
192 SENSORY LOSS 29 0.0036
193 MULTIPLE ALLERGIES 28 0.0036
194 DECUBITUS ULCER 29 0.0036
195 MAJOR DEPRESSION 26 0.0036
196 DIPLOPIA 92 0.0035
197 MUSCLE FATIGUE 15 0.0035
198 LOWER LIMB FRACTURE 68 0.0035
199 BLOOD MAGNESIUM DECREASED 30 0.0035
200 PHARYNGEAL SWELLING 34 0.0035
201 FRUSTRATION TOLERANCE DECREASED 28 0.0035
202 FORMICATION 24 0.0034
203 SPINAL FRACTURE 69 0.0034
204 HYPOAESTHESIA 514 0.0034
205 JOINT INJURY 73 0.0034
206 SKIN LACERATION 37 0.0034
207 CARDIO-RESPIRATORY ARREST 142 0.0034
208 RESPIRATORY ARREST 93 0.0034
209 PRODUCT SOLUBILITY ABNORMAL 17 0.0034
210 GASTROINTESTINAL MOTILITY DISORDER 18 0.0034
211 EYE MOVEMENT DISORDER 23 0.0034
212 TOOTH FRACTURE 37 0.0034
213 DYSARTHRIA 126 0.0033
214 SOMNOLENCE 672 0.0033
215 ORTHOSTATIC HYPOTENSION 58 0.0033
216 BLOOD POTASSIUM DECREASED 100 0.0033
217 INFUSION SITE ERYTHEMA 28 0.0033
218 HUMERUS FRACTURE 16 0.0033
219 INITIAL INSOMNIA 34 0.0033
220 MENTAL STATUS CHANGES 92 0.0033
221 PRODUCT DOSE OMISSION 216 0.0033
222 HYPOKINESIA 48 0.0033
223 INCORRECT DRUG ADMINISTRATION RATE 14 0.0033
224 BLOOD IRON DECREASED 39 0.0033
225 CONTUSION 315 0.0033
226 ROTATOR CUFF SYNDROME 42 0.0033
227 NEPHROLITHIASIS 150 0.0033
228 SKIN WARM 19 0.0033
229 HEREDITARY ANGIOEDEMA 35 0.0033
230 COGNITIVE DISORDER 152 0.0033
231 BLOOD CHOLESTEROL ABNORMAL 15 0.0032
232 HIATUS HERNIA 42 0.0032
233 ARTHRITIS INFECTIVE 15 0.0032
234 HYSTERECTOMY 28 0.0032
235 SENSITIVITY TO WEATHER CHANGE 17 0.0032
236 INFLAMMATORY MARKER INCREASED 16 0.0032
237 NEPHROTIC SYNDROME 22 0.0032
238 SINUS BRADYCARDIA 31 0.0032
239 ROAD TRAFFIC ACCIDENT 134 0.0032
240 DEPRESSION 727 0.0032
241 DYSPHEMIA 14 0.0032
242 ANAL FISTULA 17 0.0032
243 MOVEMENT DISORDER 102 0.0032
244 LARGE INTESTINE POLYP 22 0.0032
245 FOOD POISONING 17 0.0032
246 MUSCLE TWITCHING 73 0.0032
247 DRUG TOLERANCE 16 0.0032
248 WEIGHT FLUCTUATION 33 0.0032
249 INCREASED TENDENCY TO BRUISE 29 0.0031
250 BACK PAIN 730 0.0031
251 QUALITY OF LIFE DECREASED 42 0.0031
252 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16 0.0031
253 MIOSIS 25 0.0031
254 MULTIPLE FRACTURES 51 0.0031
255 VARICOSE VEIN 16 0.0031
256 APNOEA 24 0.0031
257 BLOOD THYROID STIMULATING HORMONE DECREASED 14 0.0031
258 MUSCULOSKELETAL STIFFNESS 270 0.0031
259 PSORIATIC ARTHROPATHY 125 0.0031
260 UPPER RESPIRATORY TRACT INFECTION 142 0.0031
261 UPPER LIMB FRACTURE 61 0.0031
262 AMNESIA 199 0.0031
263 JOINT RANGE OF MOTION DECREASED 41 0.0031
264 TENDON PAIN 23 0.0030
265 DIABETIC NEUROPATHY 15 0.0030
266 IRRITABLE BOWEL SYNDROME 64 0.0030
267 SEDATION 78 0.0030
268 MENTAL IMPAIRMENT 72 0.0030
269 ARTHROPOD BITE 22 0.0030
270 MUSCULOSKELETAL DISCOMFORT 51 0.0030
271 CANDIDA INFECTION 50 0.0030
272 SKIN INFECTION 33 0.0029
273 SLUGGISHNESS 30 0.0029
274 LIMB DISCOMFORT 91 0.0029
275 HALLUCINATION, VISUAL 62 0.0029
276 COVID-19 515 0.0029
277 FACIAL PARALYSIS 25 0.0029
278 FACIAL PAIN 26 0.0029
279 TREMOR 483 0.0029
280 SINUSITIS 298 0.0029
281 KIDNEY INFECTION 57 0.0029
282 CYST 36 0.0029
283 ARTHRITIS 228 0.0029
284 HALLUCINATION 218 0.0029
285 TENDERNESS 30 0.0029
286 BRAIN FOG 45 0.0029
287 SENSORY DISTURBANCE 46 0.0029
288 ANXIETY 811 0.0028
289 TOXICITY TO VARIOUS AGENTS 479 0.0028
290 DRUG INTERACTION 450 0.0028
291 DIVERTICULUM 20 0.0028
292 TOOTH INFECTION 37 0.0028
293 PERIPHERAL SWELLING 432 0.0028
294 LIMB INJURY 76 0.0028
295 OVERWEIGHT 15 0.0028
296 BURNING SENSATION 195 0.0028
297 DRUG LEVEL INCREASED 46 0.0028
298 SEIZURE 320 0.0028
299 LACERATION 26 0.0028
300 HYPERLIPIDAEMIA 33 0.0028
301 RESPIRATION ABNORMAL 19 0.0028
302 THERAPY INTERRUPTED 197 0.0028
303 BRONCHITIS 204 0.0028
304 CONCOMITANT DISEASE AGGRAVATED 17 0.0028
305 PULMONARY THROMBOSIS 30 0.0027
306 INSURANCE ISSUE 42 0.0027
307 BONE DISORDER 50 0.0027
308 THERAPEUTIC RESPONSE UNEXPECTED 123 0.0027
309 HEPATIC STEATOSIS 51 0.0027
310 HYPERTRANSAMINASAEMIA 19 0.0027
311 MIDDLE INSOMNIA 51 0.0027
312 GOUT 49 0.0027
313 CELLULITIS 137 0.0027
314 MUSCLE DISORDER 22 0.0027
315 INFUSION SITE PAIN 35 0.0027
316 GLUCOSE TOLERANCE IMPAIRED 16 0.0027
317 HYPOTONIA 27 0.0027
318 PAIN 1661 0.0027
319 OBESITY 43 0.0027
320 HEART RATE ABNORMAL 15 0.0027
321 PULMONARY MASS 40 0.0027
322 IMMUNODEFICIENCY 40 0.0027
323 BONE DENSITY DECREASED 84 0.0027
324 SPEECH DISORDER 140 0.0027
325 DISTURBANCE IN ATTENTION 144 0.0027
326 HAIR DISORDER 22 0.0027
327 PSYCHOLOGICAL TRAUMA 23 0.0027
328 DYSURIA 98 0.0027
329 COORDINATION ABNORMAL 37 0.0026
330 HEART RATE DECREASED 93 0.0026
331 VITREOUS FLOATERS 26 0.0026
332 SEXUAL DYSFUNCTION 31 0.0026
333 PARAESTHESIA 415 0.0026
334 GALLBLADDER DISORDER 47 0.0026
335 JOINT STIFFNESS 69 0.0026
336 INCOHERENT 17 0.0026
337 FEEDING DISORDER 53 0.0026
338 KNEE ARTHROPLASTY 55 0.0026
339 JOINT EFFUSION 18 0.0026
340 STAPHYLOCOCCAL INFECTION 86 0.0026
341 LYMPHOEDEMA 18 0.0026
342 MALNUTRITION 29 0.0026
343 HYPOTENSION 516 0.0026
344 DIVERTICULITIS 71 0.0026
345 ASPIRATION 28 0.0026
346 GASTROENTERITIS VIRAL 46 0.0025
347 GASTROINTESTINAL PAIN 28 0.0025
348 NIGHTMARE 88 0.0025
349 HEAD DISCOMFORT 45 0.0025
350 EUPHORIC MOOD 26 0.0025
351 DENTAL CARIES 28 0.0025
352 HOSPICE CARE 25 0.0025
353 CONSTIPATION 552 0.0025
354 IMPAIRED HEALING 83 0.0025
355 ATAXIA 30 0.0025
356 PLEURISY 15 0.0025
357 RENAL CYST 20 0.0025
358 FEELING COLD 70 0.0025
359 NIGHT SWEATS 81 0.0025
360 HYPERSOMNIA 72 0.0025
361 ANKYLOSING SPONDYLITIS 33 0.0025
362 ACUTE RESPIRATORY FAILURE 48 0.0025
363 PHARYNGITIS STREPTOCOCCAL 27 0.0025
364 BRADYCARDIA 132 0.0025
365 HYPERTHERMIA 19 0.0025
366 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 22 0.0025
367 BIPOLAR DISORDER 27 0.0025
368 PAIN IN EXTREMITY 731 0.0025
369 SLEEP DISORDER 175 0.0025
370 DIZZINESS POSTURAL 24 0.0025
371 INFLUENZA 275 0.0025
372 INSOMNIA 655 0.0025
373 DERMATITIS CONTACT 28 0.0025
374 LOW DENSITY LIPOPROTEIN INCREASED 19 0.0025
375 POST PROCEDURAL COMPLICATION 47 0.0024
376 POLYP 16 0.0024
377 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
378 TINNITUS 112 0.0024
379 HERPES ZOSTER 140 0.0024
380 APHONIA 34 0.0024
381 HYPERAESTHESIA 20 0.0024
382 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 20 0.0024
383 DEHYDRATION 323 0.0024
384 NEUROPATHY PERIPHERAL 230 0.0024
385 INFUSION SITE EXTRAVASATION 15 0.0024
386 DEVICE RELATED INFECTION 37 0.0024
387 UNRESPONSIVE TO STIMULI 62 0.0024
388 BLOOD PRESSURE DECREASED 159 0.0024
389 PANIC ATTACK 87 0.0024
390 RESPIRATORY TRACT INFECTION 62 0.0024
391 ENERGY INCREASED 14 0.0024
392 BLOOD URINE PRESENT 45 0.0024
393 POSTOPERATIVE WOUND INFECTION 16 0.0024
394 SKIN HAEMORRHAGE 35 0.0024
395 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 123 0.0024
396 HIP ARTHROPLASTY 36 0.0023
397 IMPAIRED WORK ABILITY 50 0.0023
398 KNEE OPERATION 23 0.0023
399 EAR INFECTION 62 0.0023
400 DISABILITY 46 0.0023
401 ONYCHOCLASIS 16 0.0023
402 INFLUENZA LIKE ILLNESS 191 0.0023
403 ILLNESS 239 0.0023
404 BLOOD PRESSURE ABNORMAL 46 0.0023
405 DYSKINESIA 94 0.0023
406 FLUSHING 235 0.0023
407 BURSITIS 28 0.0023
408 HYPERTENSION 488 0.0023
409 PSYCHIATRIC SYMPTOM 17 0.0023
410 LOSS OF CONSCIOUSNESS 295 0.0023
411 FEELING ABNORMAL 551 0.0023
412 SWELLING 214 0.0023
413 APHASIA 69 0.0023
414 BLOOD CALCIUM INCREASED 20 0.0023
415 GROIN PAIN 20 0.0023
416 PAPULE 16 0.0023
417 TOOTH ABSCESS 23 0.0023
418 FATIGUE 1758 0.0023
419 AUTOIMMUNE DISORDER 22 0.0023
420 FUNGAL INFECTION 75 0.0022
421 DECREASED IMMUNE RESPONSIVENESS 22 0.0022
422 FLANK PAIN 21 0.0022
423 PARALYSIS 32 0.0022
424 DRUG WITHDRAWAL SYNDROME 196 0.0022
425 POLLAKIURIA 93 0.0022
426 ABASIA 55 0.0022
427 PRODUCT DOSE OMISSION IN ERROR 63 0.0022
428 DECREASED ACTIVITY 24 0.0022
429 BLEPHAROSPASM 14 0.0022
430 SURGERY 130 0.0022
431 BLOOD CHOLESTEROL INCREASED 103 0.0022
432 ABNORMAL DREAMS 61 0.0022
433 VISION BLURRED 303 0.0022
434 ORAL HERPES 43 0.0022
435 CRYING 80 0.0022
436 DEPRESSED LEVEL OF CONSCIOUSNESS 87 0.0022
437 PROCEDURAL PAIN 61 0.0022
438 ABNORMAL FAECES 18 0.0022
439 SARS-COV-2 TEST POSITIVE 29 0.0022
440 BRAIN INJURY 22 0.0022
441 EMOTIONAL DISTRESS 265 0.0022
442 INTERNAL HAEMORRHAGE 25 0.0022
443 URINARY RETENTION 73 0.0022
444 HEADACHE 1370 0.0022
445 SINUS TACHYCARDIA 31 0.0022
446 PELVIC FRACTURE 17 0.0022
447 DRY MOUTH 177 0.0022
448 PRODUCT PHYSICAL ISSUE 44 0.0022
449 ACCIDENT 26 0.0022
450 INTESTINAL OBSTRUCTION 82 0.0022
451 GENERALISED TONIC-CLONIC SEIZURE 36 0.0022
452 BLOOD SODIUM DECREASED 41 0.0022
453 THERAPEUTIC RESPONSE SHORTENED 72 0.0022
454 DISORIENTATION 86 0.0022
455 HAIR COLOUR CHANGES 27 0.0022
456 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
457 ASTHENIA 811 0.0022
458 HEPATITIS ACUTE 14 0.0022
459 DRUG SCREEN POSITIVE 17 0.0021
460 NEUTROPHIL COUNT INCREASED 22 0.0021
461 VISUAL IMPAIRMENT 266 0.0021
462 SINUS CONGESTION 29 0.0021
463 RESPIRATORY TRACT CONGESTION 34 0.0021
464 HOT FLUSH 161 0.0021
465 THERAPY CHANGE 21 0.0021
466 BLOOD PRESSURE FLUCTUATION 51 0.0021
467 IMMUNE SYSTEM DISORDER 28 0.0021
468 ARTHROPATHY 118 0.0021
469 FEELING HOT 130 0.0021
470 HERNIA 41 0.0021
471 BASAL CELL CARCINOMA 33 0.0021
472 LOCALISED INFECTION 51 0.0021
473 TENDON RUPTURE 26 0.0021
474 SCAB 24 0.0021
475 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
476 BLOOD PRESSURE INCREASED 321 0.0021
477 HEART RATE INCREASED 208 0.0021
478 PRODUCT ADHESION ISSUE 75 0.0021
479 ORAL PAIN 47 0.0021
480 TOOTHACHE 38 0.0021
481 HYPERHIDROSIS 270 0.0021
482 HAIR TEXTURE ABNORMAL 28 0.0021
483 THINKING ABNORMAL 39 0.0021
484 ILEUS 26 0.0021
485 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
486 POOR QUALITY SLEEP 45 0.0021
487 SKIN ULCER 54 0.0021
488 DIZZINESS 1041 0.0021
489 BREAST MASS 14 0.0021
490 COLITIS ISCHAEMIC 14 0.0021
491 NAUSEA 1642 0.0021
492 MADAROSIS 24 0.0021
493 MUSCULOSKELETAL CHEST PAIN 32 0.0021
494 ERUCTATION 40 0.0021
495 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
496 CONFUSIONAL STATE 333 0.0021
497 NOCTURIA 25 0.0021
498 TACHYPNOEA 28 0.0021
499 ARTHRALGIA 856 0.0021
500 PARKINSONISM 20 0.0020
501 VERTIGO 125 0.0020
502 ORAL CANDIDIASIS 27 0.0020
503 HEMIPLEGIA 17 0.0020
504 MUSCULOSKELETAL PAIN 107 0.0020
505 RHINORRHOEA 132 0.0020
506 OROPHARYNGEAL PAIN 189 0.0020
507 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 112 0.0020
508 ANGER 69 0.0020
509 INFECTION 295 0.0020
510 HEART RATE IRREGULAR 46 0.0020
511 POOR VENOUS ACCESS 21 0.0020
512 GLAUCOMA 39 0.0020
513 CLOSTRIDIUM DIFFICILE INFECTION 44 0.0020
514 CHOLECYSTITIS 24 0.0020
515 AUTOIMMUNE HEPATITIS 14 0.0020
516 HEPATIC ENZYME INCREASED 137 0.0020
517 WOUND INFECTION 22 0.0020
518 DYSPHAGIA 190 0.0020
519 FEELING JITTERY 38 0.0020
520 NODULE 26 0.0020
521 DYSPEPSIA 196 0.0020
522 SCAR 34 0.0020
523 FOOT DEFORMITY 22 0.0020
524 ALTERED STATE OF CONSCIOUSNESS 43 0.0020
525 THROAT IRRITATION 89 0.0020
526 CHOLELITHIASIS 65 0.0020
527 OXYGEN SATURATION DECREASED 111 0.0020
528 PRESYNCOPE 48 0.0020
529 ABDOMINAL DISCOMFORT 330 0.0020
530 SEPSIS 219 0.0020
531 BOWEL MOVEMENT IRREGULARITY 15 0.0020
532 CONDITION AGGRAVATED 595 0.0020
533 PALPITATIONS 229 0.0020
534 BONE PAIN 114 0.0019
535 ESCHERICHIA INFECTION 16 0.0019
536 DISCOMFORT 118 0.0019
537 IMMUNOSUPPRESSION 17 0.0019
538 CHILLS 225 0.0019
539 PETECHIAE 20 0.0019
540 SKIN DISCOLOURATION 88 0.0019
541 GASTROINTESTINAL INFLAMMATION 15 0.0019
542 POISONING 24 0.0019
543 AFFECTIVE DISORDER 15 0.0019
544 INTENTIONAL PRODUCT MISUSE 167 0.0019
545 AKATHISIA 26 0.0019
546 THIRST 34 0.0019
547 ACUTE HEPATIC FAILURE 26 0.0019
548 GASTROINTESTINAL INFECTION 17 0.0019
549 EYE PAIN 107 0.0019
550 INTENTIONAL DOSE OMISSION 54 0.0019
551 PNEUMONIA 611 0.0019
552 GINGIVAL PAIN 15 0.0019
553 TOOTH LOSS 39 0.0019
554 EATING DISORDER 40 0.0019
555 RESPIRATORY DEPRESSION 23 0.0019
556 ORAL DISCOMFORT 26 0.0019
557 RENAL IMPAIRMENT 157 0.0019
558 RHEUMATOID ARTHRITIS 212 0.0019
559 HIP FRACTURE 60 0.0019
560 GASTRIC DISORDER 64 0.0019
561 BODY TEMPERATURE INCREASED 38 0.0019
562 FRACTURE 35 0.0018
563 VOMITING 869 0.0018
564 CHOKING 36 0.0018
565 WEIGHT DECREASED 515 0.0018
566 WEIGHT INCREASED 413 0.0018
567 LETHARGY 106 0.0018
568 GASTRIC ULCER 35 0.0018
569 ASTHMA 208 0.0018
570 THROMBOSIS 148 0.0018
571 SYNCOPE 184 0.0018
572 CHOLECYSTECTOMY 21 0.0018
573 LYMPHOPENIA 26 0.0018
574 EYE DISCHARGE 19 0.0018
575 ALOPECIA 359 0.0018
576 EYE DISORDER 60 0.0018
577 NASOPHARYNGITIS 336 0.0018
578 JOINT SWELLING 220 0.0018
579 MUSCLE ATROPHY 23 0.0018
580 INTENTIONAL PRODUCT USE ISSUE 159 0.0018
581 PSORIASIS 237 0.0018
582 ABDOMINAL PAIN UPPER 373 0.0018
583 PRODUCT DOSE OMISSION ISSUE 532 0.0018
584 PRESCRIBED UNDERDOSE 36 0.0018
585 EAR PAIN 35 0.0018
586 PAIN IN JAW 51 0.0018
587 SKIN DISORDER 60 0.0018
588 DEPRESSED MOOD 95 0.0018
589 MYALGIA 305 0.0018
590 MENTAL DISORDER 78 0.0018
591 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
592 DIARRHOEA 1156 0.0018
593 MASS 25 0.0018
594 SMALL INTESTINAL OBSTRUCTION 22 0.0018
595 DELIRIUM 62 0.0018
596 GASTRITIS 47 0.0018
597 DRUG-INDUCED LIVER INJURY 56 0.0018
598 FEAR 48 0.0018
599 METABOLIC ACIDOSIS 57 0.0018
600 RETCHING 38 0.0018
601 TRANSIENT ISCHAEMIC ATTACK 60 0.0018
602 HYPOTHERMIA 18 0.0018
603 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
604 TASTE DISORDER 36 0.0018
605 EYELID PTOSIS 18 0.0018
606 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
607 FURUNCLE 14 0.0018
608 INADEQUATE ANALGESIA 15 0.0018
609 CHEST PAIN 326 0.0018
610 COLD SWEAT 31 0.0018
611 SECRETION DISCHARGE 22 0.0018
612 WHEEZING 104 0.0018
613 EAR DISCOMFORT 18 0.0018
614 FLUID RETENTION 89 0.0017
615 TACHYCARDIA 155 0.0017
616 CHEST DISCOMFORT 178 0.0017
617 DELUSION 27 0.0017
618 HEPATOMEGALY 17 0.0017
619 SWOLLEN TONGUE 54 0.0017
620 LABORATORY TEST ABNORMAL 51 0.0017
621 DYSPHONIA 101 0.0017
622 HYPOAESTHESIA ORAL 26 0.0017
623 ELECTROCARDIOGRAM QT PROLONGED 62 0.0017
624 HYPOPHAGIA 44 0.0017
625 NASAL CONGESTION 101 0.0017
626 INJECTION SITE BRUISING 137 0.0017
627 BACTERIAL INFECTION 32 0.0017
628 LEUKOCYTOSIS 31 0.0017
629 VIRAL INFECTION 57 0.0017
630 INABILITY TO AFFORD MEDICATION 17 0.0017
631 PRESCRIBED OVERDOSE 33 0.0017
632 INFUSION RELATED REACTION 113 0.0017
633 NERVOUSNESS 89 0.0017
634 INJECTION SITE REACTION 117 0.0017
635 CARDIAC ARREST 140 0.0017
636 MALAISE 740 0.0017
637 ABDOMINAL PAIN 392 0.0017
638 PARANOIA 29 0.0017
639 ABDOMINAL DISTENSION 175 0.0017
640 FLATULENCE 95 0.0017
641 PERIPHERAL COLDNESS 23 0.0017
642 BLISTER 94 0.0017
643 MUSCLE RIGIDITY 20 0.0017
644 BLOOD UREA INCREASED 28 0.0017
645 SUICIDAL IDEATION 153 0.0017
646 STOMATITIS 101 0.0017
647 OSTEOMYELITIS 30 0.0017
648 ATELECTASIS 16 0.0017
649 INFLAMMATION 85 0.0016
650 APPLICATION SITE ERYTHEMA 43 0.0016
651 LYMPHADENOPATHY 58 0.0016
652 PRODUCT PRESCRIBING ERROR 39 0.0016
653 ELECTROLYTE IMBALANCE 19 0.0016
654 NERVOUS SYSTEM DISORDER 51 0.0016
655 AGITATION 120 0.0016
656 TYPE 2 DIABETES MELLITUS 55 0.0016
657 MOOD SWINGS 52 0.0016
658 THERAPEUTIC PRODUCT EFFECT DECREASED 73 0.0016
659 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
660 DECREASED APPETITE 378 0.0016
661 UNEVALUABLE EVENT 123 0.0016
662 OEDEMA 88 0.0016
663 WHITE BLOOD CELL COUNT INCREASED 62 0.0016
664 TENDONITIS 25 0.0016
665 SCRATCH 17 0.0016
666 WOUND 45 0.0016
667 TOOTH EXTRACTION 20 0.0016
668 EYE INFECTION 18 0.0016
669 MYOCLONUS 19 0.0016
670 HAEMORRHOIDS 31 0.0016
671 FULL BLOOD COUNT DECREASED 32 0.0016
672 CONTRAINDICATED PRODUCT ADMINISTERED 48 0.0016
673 PRODUCT SUBSTITUTION ISSUE 91 0.0016
674 VENTRICULAR TACHYCARDIA 26 0.0016
675 ULCER 25 0.0016
676 INJECTION SITE MASS 58 0.0016
677 ADRENAL INSUFFICIENCY 19 0.0016
678 DEVICE OCCLUSION 22 0.0016
679 SNEEZING 35 0.0016
680 BLINDNESS UNILATERAL 22 0.0016
681 THYROID DISORDER 24 0.0016
682 FEMUR FRACTURE 48 0.0015
683 IRRITABILITY 93 0.0015
684 CARDIOMEGALY 19 0.0015
685 PALLOR 42 0.0015
686 INJECTION SITE INDURATION 20 0.0015
687 PHOTOPHOBIA 29 0.0015
688 GINGIVAL BLEEDING 21 0.0015
689 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17 0.0015
690 SKIN LESION 42 0.0015
691 DEAFNESS 40 0.0015
692 TRANSFUSION 16 0.0015
693 PARAESTHESIA ORAL 22 0.0015
694 PRODUCT USE COMPLAINT 24 0.0015
695 HYPERTHYROIDISM 22 0.0015
696 URTICARIA 254 0.0015
697 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
698 ILL-DEFINED DISORDER 92 0.0015
699 CATARACT 90 0.0015
700 DIABETES MELLITUS 115 0.0015
701 INJECTION SITE URTICARIA 37 0.0015
702 HUNGER 21 0.0015
703 INJECTION SITE WARMTH 31 0.0015
704 HYPOXIA 53 0.0015
705 HYPOTHYROIDISM 48 0.0015
706 RESTLESSNESS 55 0.0015
707 OVARIAN CYST 15 0.0015
708 APPLICATION SITE PAIN 33 0.0015
709 WHITE BLOOD CELL COUNT DECREASED 162 0.0015
710 THERAPY NON-RESPONDER 67 0.0015
711 LACRIMATION INCREASED 45 0.0015
712 DRUG DOSE OMISSION 246 0.0015
713 EMPHYSEMA 15 0.0015
714 DRUG EFFECT INCOMPLETE 54 0.0015
715 SKIN FISSURES 29 0.0015
716 FAECES DISCOLOURED 32 0.0015
717 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 105 0.0015
718 DRY THROAT 15 0.0015
719 HYPOKALAEMIA 68 0.0015
720 PULMONARY EMBOLISM 140 0.0015
721 HYPOACUSIS 63 0.0015
722 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
723 RASH MACULAR 51 0.0015
724 CORONARY ARTERY OCCLUSION 20 0.0015
725 AFFECT LABILITY 14 0.0015
726 DYSGEUSIA 108 0.0015
727 PHARYNGITIS 18 0.0014
728 SEPTIC SHOCK 63 0.0014
729 HALLUCINATION, AUDITORY 23 0.0014
730 DEEP VEIN THROMBOSIS 94 0.0014
731 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
732 RECTAL HAEMORRHAGE 62 0.0014
733 PRURITUS 553 0.0014
734 RENAL DISORDER 67 0.0014
735 COUGH 402 0.0014
736 EMOTIONAL DISORDER 44 0.0014
737 RENAL PAIN 15 0.0014
738 RESPIRATORY DISORDER 42 0.0014
739 HAEMATURIA 48 0.0014
740 RED BLOOD CELL COUNT DECREASED 40 0.0014
741 HAEMOPTYSIS 39 0.0014
742 BONE LOSS 21 0.0014
743 CARDIAC FAILURE CONGESTIVE 112 0.0014
744 ACCIDENTAL OVERDOSE 51 0.0014
745 DYSPNOEA 789 0.0014
746 DRUG EFFECT DECREASED 75 0.0014
747 ADVERSE DRUG REACTION 125 0.0014
748 PNEUMOTHORAX 22 0.0014
749 UNDERDOSE 101 0.0014
750 DRY EYE 69 0.0014
751 SYSTEMIC LUPUS ERYTHEMATOSUS 49 0.0014
752 COLITIS 52 0.0014
753 GASTROENTERITIS 20 0.0014
754 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
755 OEDEMA PERIPHERAL 166 0.0014
756 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
757 BLOOD POTASSIUM INCREASED 22 0.0014
758 DYSPNOEA EXERTIONAL 51 0.0014
759 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
760 CARDIOMYOPATHY 20 0.0014
761 LIP SWELLING 45 0.0013
762 GASTROINTESTINAL DISORDER 121 0.0013
763 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
764 TRANSAMINASES INCREASED 30 0.0013
765 SHOCK 31 0.0013
766 PRODUCTIVE COUGH 64 0.0013
767 DYSTONIA 26 0.0013
768 OSTEONECROSIS 44 0.0013
769 INCORRECT PRODUCT ADMINISTRATION DURATION 29 0.0013
770 OCULAR DISCOMFORT 15 0.0013
771 PRODUCT DISPENSING ERROR 29 0.0013
772 THROAT TIGHTNESS 36 0.0013
773 CARDIOGENIC SHOCK 19 0.0013
774 PELVIC PAIN 24 0.0013
775 LOCAL SWELLING 23 0.0013
776 ABSCESS 21 0.0013
777 PROTEINURIA 25 0.0013
778 RASH PRURITIC 71 0.0013
779 LIVER FUNCTION TEST ABNORMAL 38 0.0013
780 SWELLING FACE 85 0.0013
781 PLATELET COUNT INCREASED 17 0.0013
782 HYPERSENSITIVITY 242 0.0013
783 SUICIDE ATTEMPT 79 0.0013
784 BLOOD GLUCOSE ABNORMAL 24 0.0013
785 INTENTIONAL OVERDOSE 83 0.0013
786 POST PROCEDURAL HAEMORRHAGE 15 0.0013
787 MOOD ALTERED 35 0.0013
788 AGEUSIA 32 0.0013
789 ADVERSE REACTION 17 0.0013
790 MANIA 21 0.0013
791 COLON CANCER 19 0.0013
792 EYE HAEMORRHAGE 17 0.0013
793 INJECTION SITE RASH 39 0.0013
794 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
795 DEVICE ISSUE 113 0.0013
796 HYPERTENSIVE CRISIS 14 0.0013
797 MACULAR DEGENERATION 15 0.0013
798 INCREASED APPETITE 24 0.0013
799 INJURY 88 0.0013
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 89 0.0012
801 RASH 544 0.0012
802 ANOSMIA 18 0.0012
803 DRUG INEFFECTIVE 1638 0.0012
804 EYE SWELLING 46 0.0012
805 APPLICATION SITE PRURITUS 28 0.0012
806 APATHY 18 0.0012
807 PRODUCT USE IN UNAPPROVED INDICATION 305 0.0012
808 NO THERAPEUTIC RESPONSE 15 0.0012
809 HYPOMAGNESAEMIA 17 0.0012
810 TOOTH DISORDER 27 0.0012
811 PYREXIA 420 0.0012
812 OFF LABEL USE 1058 0.0012
813 SICKLE CELL ANAEMIA WITH CRISIS 19 0.0012
814 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
815 PRURITUS GENERALISED 26 0.0012
816 HYPOGLYCAEMIA 58 0.0012
817 HEPATIC FAILURE 36 0.0012
818 RASH ERYTHEMATOUS 57 0.0012
819 EPISTAXIS 89 0.0012
820 ALANINE AMINOTRANSFERASE INCREASED 73 0.0012
821 BLOOD COUNT ABNORMAL 18 0.0012
822 ACUTE MYOCARDIAL INFARCTION 35 0.0012
823 ABNORMAL BEHAVIOUR 47 0.0012
824 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
825 DEMENTIA 33 0.0012
826 INJECTION SITE PRURITUS 79 0.0012
827 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
828 PRODUCT USE ISSUE 221 0.0012
829 HEPATIC CIRRHOSIS 22 0.0012
830 MYDRIASIS 15 0.0012
831 GASTROINTESTINAL HAEMORRHAGE 97 0.0012
832 EXTRA DOSE ADMINISTERED 47 0.0012
833 OVERDOSE 250 0.0012
834 ANAEMIA 220 0.0012
835 CHROMATURIA 26 0.0012
836 SKIN EXFOLIATION 97 0.0011
837 PRODUCT QUALITY ISSUE 156 0.0011
838 INJECTION SITE SWELLING 88 0.0011
839 EPILEPSY 35 0.0011
840 INJECTION SITE ERYTHEMA 141 0.0011
841 PANCREATITIS 60 0.0011
842 BLOOD CREATININE INCREASED 74 0.0011
843 TREATMENT NONCOMPLIANCE 62 0.0011
844 INJECTION SITE HAEMORRHAGE 90 0.0011
845 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 203 0.0011
846 RESPIRATORY DISTRESS 31 0.0011
847 LUNG DISORDER 55 0.0011
848 MALIGNANT MELANOMA 15 0.0011
849 LIVER FUNCTION TEST INCREASED 24 0.0011
850 PSYCHOTIC DISORDER 33 0.0011
851 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
852 PRODUCT TASTE ABNORMAL 15 0.0011
853 ABDOMINAL PAIN LOWER 28 0.0011
854 PHARYNGEAL OEDEMA 17 0.0011
855 THERAPEUTIC RESPONSE DECREASED 67 0.0011
856 HOSPITALISATION 169 0.0011
857 PRODUCT AVAILABILITY ISSUE 25 0.0011
858 RESPIRATORY FAILURE 80 0.0011
859 EYE IRRITATION 63 0.0011
860 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 219 0.0011
861 BLINDNESS 44 0.0011
862 PULMONARY OEDEMA 48 0.0011
863 INJECTION SITE PAIN 328 0.0011
864 BLOOD TEST ABNORMAL 15 0.0011
865 HAEMORRHAGE 111 0.0011
866 HAEMATOCRIT DECREASED 21 0.0011
867 RHABDOMYOLYSIS 44 0.0011
868 DEVICE FAILURE 16 0.0010
869 ERYTHEMA 216 0.0010
870 CARDIAC DISORDER 98 0.0010
871 HAEMATOMA 27 0.0010
872 DIABETIC KETOACIDOSIS 25 0.0010
873 PAIN OF SKIN 28 0.0010
874 NEEDLE ISSUE 30 0.0010
875 TARDIVE DYSKINESIA 29 0.0010
876 CEREBROVASCULAR ACCIDENT 174 0.0010
877 SKIN CANCER 22 0.0010
878 ATRIAL FIBRILLATION 99 0.0010
879 PULMONARY HYPERTENSION 21 0.0010
880 PLEURAL EFFUSION 61 0.0010
881 BLOOD GLUCOSE DECREASED 48 0.0010
882 HYPERKALAEMIA 35 0.0010
883 INCORRECT DRUG ADMINISTRATION DURATION 28 0.0010
884 ANAPHYLACTIC REACTION 55 0.0010
885 PERICARDIAL EFFUSION 23 0.0010
886 EXPIRED PRODUCT ADMINISTERED 33 0.0010
887 LIVER DISORDER 44 0.0010
888 DRUG DISPENSING ERROR 15 0.0010
889 BRONCHOSPASM 14 0.0010
890 PANCREATITIS ACUTE 22 0.0010
891 TREATMENT FAILURE 81 0.0010
892 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
893 PHOTOSENSITIVITY REACTION 16 0.0010
894 AGGRESSION 48 0.0010
895 DERMATITIS 20 0.0010
896 HAEMOGLOBIN DECREASED 98 0.0010
897 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
898 EYE PRURITUS 32 0.0010
899 HEPATOTOXICITY 21 0.0009
900 GLOSSODYNIA 21 0.0009
901 DRY SKIN 125 0.0009
902 MYOCARDIAL INFARCTION 162 0.0009
903 BLOOD BILIRUBIN INCREASED 25 0.0009
904 DEVICE DISLOCATION 40 0.0009
905 BLOOD GLUCOSE INCREASED 173 0.0009
906 PRODUCT PRESCRIBING ISSUE 20 0.0009
907 MEDICATION ERROR 51 0.0009
908 DEVICE MALFUNCTION 64 0.0009
909 CARDIAC FAILURE 73 0.0009
910 HAEMATEMESIS 23 0.0009
911 OCULAR HYPERAEMIA 43 0.0009
912 COAGULOPATHY 15 0.0009
913 PRODUCT ADMINISTRATION ERROR 18 0.0009
914 FREQUENT BOWEL MOVEMENTS 24 0.0009
915 PULMONARY FIBROSIS 17 0.0009
916 NEOPLASM MALIGNANT 59 0.0009
917 DISEASE RECURRENCE 42 0.0009
918 CARDIOVASCULAR DISORDER 22 0.0009
919 SKIN BURNING SENSATION 61 0.0009
920 HYPERGLYCAEMIA 31 0.0008
921 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
922 DRUG ABUSE 70 0.0008
923 DRUG DEPENDENCE 133 0.0008
924 CIRCULATORY COLLAPSE 14 0.0008
925 ECZEMA 43 0.0008
926 EXTRAPYRAMIDAL DISORDER 20 0.0008
927 ANGINA PECTORIS 23 0.0008
928 INCORRECT DOSE ADMINISTERED BY DEVICE 21 0.0008
929 DERMATITIS ATOPIC 42 0.0008
930 PLASMA CELL MYELOMA 31 0.0008
931 INCORRECT DOSE ADMINISTERED 179 0.0008
932 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
933 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
934 DEVICE LEAKAGE 33 0.0008
935 VAGINAL HAEMORRHAGE 33 0.0008
936 ADVERSE EVENT 70 0.0008
937 VISUAL ACUITY REDUCED 25 0.0008
938 CONVULSION 43 0.0008
939 PLATELET COUNT DECREASED 80 0.0007
940 GASTRIC CANCER 19 0.0007
941 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
942 HAEMATOCHEZIA 41 0.0007
943 HEPATITIS 19 0.0007
944 SKIN IRRITATION 34 0.0007
945 ERECTILE DYSFUNCTION 19 0.0007
946 ARRHYTHMIA 35 0.0007
947 CEREBRAL INFARCTION 18 0.0007
948 LIVER INJURY 18 0.0007
949 CORONARY ARTERY DISEASE 22 0.0007
950 DRUG INTOLERANCE 70 0.0007
951 PERITONITIS 15 0.0007
952 DISEASE PROGRESSION 85 0.0007
953 RASH PAPULAR 16 0.0007
954 COLITIS ULCERATIVE 31 0.0007
955 INJURY ASSOCIATED WITH DEVICE 14 0.0007
956 PRODUCT COMPLAINT 17 0.0007
957 CEREBRAL HAEMORRHAGE 24 0.0007
958 ACNE 50 0.0007
959 EXPOSURE VIA SKIN CONTACT 17 0.0007
960 HEPATIC FUNCTION ABNORMAL 24 0.0006
961 LEUKOPENIA 32 0.0006
962 LUNG NEOPLASM MALIGNANT 26 0.0006
963 DEATH 535 0.0006
964 ASCITES 18 0.0006
965 ACCIDENTAL EXPOSURE TO PRODUCT 61 0.0006
966 DEVICE BREAKAGE 24 0.0006
967 LACTIC ACIDOSIS 19 0.0006
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27 0.0006
969 PNEUMONITIS 15 0.0006
970 ANGIOEDEMA 24 0.0005
971 PANCYTOPENIA 30 0.0005
972 PANCREATIC CARCINOMA 15 0.0005
973 RENAL FAILURE ACUTE 22 0.0005
974 PRODUCT STORAGE ERROR 45 0.0005
975 THROMBOCYTOPENIA 57 0.0005
976 NEUTROPHIL COUNT DECREASED 20 0.0005
977 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
978 NEUTROPENIA 64 0.0005
979 NEOPLASM PROGRESSION 16 0.0005
980 NO ADVERSE EVENT 81 0.0004
981 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
982 BREAST CANCER 41 0.0004
983 FEBRILE NEUTROPENIA 29 0.0004
984 DRUG DOSE OMISSION BY DEVICE 34 0.0004
985 HYPONATRAEMIA 23 0.0004
986 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
987 DEVICE DIFFICULT TO USE 26 0.0004
988 INTERSTITIAL LUNG DISEASE 19 0.0004
989 C-REACTIVE PROTEIN INCREASED 14 0.0004
990 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
991 MALIGNANT NEOPLASM PROGRESSION 34 0.0003